Van Well Daan 4/A
4/A · SOPHiA GENETICS SA · Filed Apr 8, 2026
Research Summary
AI-generated summary of this filing
SOPHiA GENETICS (SOPH) CLO Daan Van Well Receives RSU Award
What Happened
Daan Van Well, Chief Legal Officer of SOPHiA GENETICS SA (SOPH), received equity awards on 2026-04-02: 97,536 restricted stock units (RSUs) and 142,216 derivative RSUs (both reported as acquisitions at $0.00), for a total of 239,752 awarded/derivative units. After the transaction the corrected beneficial ownership is 358,774 ordinary shares (per amended filing). These are awards (not purchases or sales) and require continued service to vest.
Key Details
- Transaction date: 2026-04-02; Form 4/A filed 2026-04-08 to amend prior Form 4 (filed 2026-04-03).
- Reported consideration: $0.00 per share for both items (award/grant code A).
- New awards: 97,536 RSUs + 142,216 derivative RSUs = 239,752 units.
- Shares beneficially owned following transaction (corrected): 358,774 ordinary shares (correction from originally reported 97,536).
- Footnote F1: RSUs granted under the 2021 Equity Incentive Plan; each RSU converts to one ordinary share upon vesting and is contingent on continued service. 25% vests on April 2, 2027, remainder vests in equal quarterly installments through April 2, 2030.
- Footnote F2: This is an amended filing to correct the amount in Column 5 (beneficial ownership).
- Filing timeliness: original Form 4 was filed promptly (Apr 3) for the Apr 2 transaction; this Form 4/A corrects a reporting error (not a late-report signal).
Context
RSUs are derivative awards that convert to actual shares only as they vest; they do not represent an immediate cash purchase or sale. Grants like this are common for executive compensation and signal company-level retention/compensation actions rather than an open-market bet by the insider. The amended Form 4 simply corrects the reported post-transaction ownership total.
Insider Transaction Report
- Award
Ordinary Shares
[F1][F2]2026-04-02+97,536→ 358,774 total - Award
Share Option (Right to Buy)
[F3]2026-04-02+142,216→ 142,216 totalExercise: $5.04Exp: 2036-04-02→ Ordinary Shares (142,216 underlying)
Footnotes (3)
- [F1]Represents a restricted stock unit ("RSU") grant made under the Issuer's 2021 Equity Incentive Plan. Each RSU represents a contingent right to receive one ordinary share of the Issuer, subject to the Reporting Person's continued service with the Issuer. 25% of the RSUs will vest on April 2, 2027, and the remaining 75% will vest in equal quarterly installments through April 2, 2030.
- [F2]This Form 4/A amends the Form 4 filed on April 3, 2026 to correct the amount reported in Column 5 (Amount of Securities Beneficially Owned Following Reported Transaction), which was previously reported as 97,536 ordinary shares due to an inadvertent error. The correct amount is 358,774 ordinary shares.
- [F3]The share option vests and becomes exercisable as to 25% of the ordinary shares on April 2, 2027, and then in equal monthly installments through April 2, 2030.